Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma
Molecular Cell · 2024
DOI: 10.1016/j.molcel.2023.12.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2024. Verfasst von Lianxin Hu und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
TANK-binding kinase 1 (TBK1) is a potential therapeutic target in multiple cancers, including clear cell renal cell carcinoma (ccRCC). However, targeting TBK1 in clinical practice is challenging. One approach to overcome this challenge would be to identify an upstream TBK1 regulator that could be targeted therapeutically in cancer specifically. In this study, we perform a kinome-wide small interfering RNA (siRNA) screen and identify doublecortin-like kinase 2 (DCLK2) as a TBK1 regulator in ccRCC. DCLK2 binds to and directly phosphorylates TBK1 on Ser172. Depletion of DCLK2 inhibits anchorage-independent colony growth and kidney tumorigenesis in orthotopic xenograft models. Conversely, overexpression of DCLK2203, a short isoform that predominates in ccRCC, promotes ccRCC cell growth and tumorigenesis in vivo. Mechanistically, DCLK2203 elicits its oncogenic signaling via TBK1 phosphorylation and activation. Taken together, these results suggest that DCLK2 is a TBK1 activator and potential therapeutic target for ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC 27599, USA.
- Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Förderung
- NCI NIH HHS
- NIA NIH HHS
- National Institutes of Health
- National Cancer Institute
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Hu, L., Zhang, Y., Guo, L., Zhong, H., Xie, L., Zhou, J., Liao, C., Yao, H., Fang, J., Liu, H., Zhang, C., Zhang, H., Zhu, X., Luo, M., von Kriegsheim, A., Li, B., Luo, W., Zhang, X., Chen, X., …, & Zhang, Q. (2024). Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma. Molecular Cell. https://doi.org/10.1016/j.molcel.2023.12.010
Vancouver
Hu L, Zhang Y, Guo L, Zhong H, Xie L, Zhou J, et al. Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma. Molecular Cell. 2024. doi:10.1016/j.molcel.2023.12.010
BibTeX
@article{Hu2024,
author = {Hu, Lianxin and Zhang, Yanfeng and Guo, Lei and Zhong, Hua and Xie, Ling and Zhou, Jin and Liao, Chengheng and Yao, Hongwei and Fang, Jun and Liu, Hongyi and Zhang, Cheng and Zhang, Hui and Zhu, Xiaoqiang and Luo, Maowu and von Kriegsheim, Alex and Li, Bufan and Luo, Weibo and Zhang, Xuewu and Chen, Xian and Mendell, Joshua T and Xu, Lin and Kapur, Payal and Baldwin, Albert S and Brugarolas, James and Zhang, Qing},
title = {Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma},
journal = {Molecular Cell},
year = {2024},
doi = {10.1016/j.molcel.2023.12.010}
}
EUVIMED